{"id":5301,"date":"2014-11-19T15:03:57","date_gmt":"2014-11-19T14:03:57","guid":{"rendered":"http:\/\/www.fedaiisf.it\/?p=5301"},"modified":"2014-11-20T13:18:54","modified_gmt":"2014-11-20T12:18:54","slug":"parafarmacie-aziende-farmaceutiche","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/parafarmacie-aziende-farmaceutiche\/","title":{"rendered":"Parapharmacies on pharmaceutical companies. \u201cUnfair Trade Practices\u201d"},"content":{"rendered":"<p><i>Discriminazione tra farmacie e parafarmacie quanto a tempi, condizioni, quantit\u00e0 e prezzi di fornitura &#8211; costituiscono casi di pratica commerciale scorretta<\/i><\/p>\n<p><a href=\"http:\/\/streamer.adnkronos.com\/Salute\/Newsletter\/data\/Pk17614.pdf\" target=\"_blank\" rel=\"noopener\">19 novembre 2014 &#8211; PharmaKronos<\/a><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignleft\" alt=\"\" src=\"data:image\/jpeg;base64,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\" width=\"120\" height=\"120\" \/>Le parafarmacie scendono in campo contro le &#8220;pratiche commerciali sleali&#8221; delle aziende farmaceutiche. In una lettera a oltre 100 imprese il presidente della Federazione nazionale Parafarmacie italiane, <strong>David Gullotta<\/strong>, scrive che &#8220;le condizioni contrattuali e le prassi commerciali adottate dalle imprese di farmaci &#8211; che si risolvono in una ingiustificata discriminazione tra farmacie e parafarmacie quanto a tempi, condizioni, quantit\u00e0 e prezzi di fornitura &#8211; costituiscono casi di pratica commerciale scorretta.<\/p>\n<p>Il decreto <a href=\"http:\/\/www.governo.it\/backoffice\/allegati\/65684-7206.pdf\" target=\"_blank\" rel=\"noopener\">legge 201 del 6 dicembre 2011<\/a> \u00e8 chiaro al riguardo sono purtroppo molte le aziende che applicano condizioni diverse solo sulla base di una differente denominazione sociale (farmacia o parafarmacia). La federazione vigiler\u00e0 perch\u00e9 tale direttiva venga recepita, e ogni eccezione sar\u00e0 vagliata dal nostro ufficio legale&#8221;.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignright\" alt=\"\" src=\"https:\/\/encrypted-tbn2.gstatic.com\/images?q=tbn:ANd9GcTbypvkcoOJ9JF6hx0N06H4svo1yA5k7DGHo-WifwWD-rNGZxpHAA\" width=\"227\" height=\"80\" \/>Nella lettera, inoltre, le parafarmacie invitano le stesse aziende &#8220;a porre particolare attenzione ai messaggi pubblicitari, televisivi, cartacei o di altra natura, affinch\u00e9 venga specificata la presenza di un particolare prodotto sia in farmacia che in parafarmacia, onde evitare il rischio che si prefigurino danni economici per informazioni scorrette o incomplete&#8221;.<\/p>\n<p><span style=\"color: #ff0000;\"><b>Ed<\/b><\/span>.: <i>DECRETO-LEGGE 6 dicembre 2011 , n. 201 Art. 32<\/i><i>\u00a0<\/i><\/p>\n<p><i>\u00a0Pharmacies<\/i><\/p>\n<p><i>3. Le condizioni contrattuali e le prassi commerciali adottate dalle\u00a0 imprese di produzione o di distribuzione dei farmaci che si risolvono\u00a0 in una ingiustificata discriminazione tra farmacie e parafarmacie quanto ai tempi, alle condizioni, alle quantit\u00e0 ed ai prezzi di\u00a0 fornitura, costituiscono casi di pratica commerciale sleale ai fini\u00a0 dell&#8217;applicazione delle vigenti disposizioni in materia<\/i>.<\/p>","protected":false},"excerpt":{"rendered":"<p>Discriminazione tra farmacie e parafarmacie quanto a tempi, condizioni, quantit\u00e0 e prezzi di fornitura &#8211; costituiscono casi di pratica commerciale scorretta 19 novembre 2014 &#8211; PharmaKronos Le parafarmacie scendono in campo contro le &#8220;pratiche commerciali sleali&#8221; delle aziende farmaceutiche. In una lettera a oltre 100 imprese il presidente della Federazione nazionale Parafarmacie italiane, Davide Gullotta, &hellip;<\/p>","protected":false},"author":4,"featured_media":4445,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[50,41],"class_list":["post-5301","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizie","tag-farmindustria","tag-leggisentenze"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/5301","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=5301"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/5301\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/4445"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=5301"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=5301"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=5301"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}